“Favorites of Success” logo The drug from the common cold :: Consumers survey results of for 1 quarter of 2024
© FAVOR.com.ua
 
Consumers survey results of for 1 quarter of 2024 in category
Cold and Flu / The drug from the common cold
Info The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.
I quarter (january—march)
II quarter (april—june)
1. Отривін (Novartis OTC) 75.00% 5
2. Quixx (Berlin-Chemie Menarini) 50.00% 3.33
2. Піносол (Zentiva) 50.00% 3.33
4. IRS 19 (Abbott Laboratories) 25.00% 1.67
4. Галазолін (Polpharma S.A.) 25.00% 1.67
4. Галазолін (ICN Polfa Rzeszow) 25.00% 1.67
4. Грипостад Ріно (Nizhpharm) 25.00% 1.67
4. Евказолін Аква (Farmak) 25.00% 1.67
4. Назолін-Дарниця (Darnitsa) 25.00% 1.67
4. Фармазолін (Farmak) 25.00% 1.67

Notice This rating reflects the current interim results of the study of public opinion as on 6/16/2024 0:59:07 and it’s not yet final.
Strictly prohibited any use and reproduction of unfinished voting results without link to the source, without clear explanation of the methodology of the “Favorites of Success” Contest and without mandatory notes that poll is still continues and this result is not yet final.
https://favor.com.ua/en/vote/products/rhinitis/?results=20241